Prohost Letter #408

Prohost Letter #408
AT A GLANCE -

Continued from the Previous Prohost Letter #408

In the Past issue #407, we picked the following firms:

NEUROCRINE BIOSCIENCES (NBIX)

Treating Tardive Dyskinesia

CYTOMX

Improving On Cancer Immunotherapy
CELYAD SA (CYAD)
Bringing Solutions To Immunotherapy Problems

Please Read the articles written about these firms in the Issue #407
In This Issue We Add 
NEW LINK GENETICS...

This content is for paid subscribers.
Please click here to subscribe or here to log in.